- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01070134
Mindfulness-based Behavioural Therapy (MIBT) Versus Psychodynamic Therapy for Patients With Major Depressive Disorder in Psychotherapeutic Day Treatment. A Randomised Clinical Pilot Trial (Mipsy)
Background:
According to the WHO, major depressive disorder is the second largest healthcare problem worldwide in terms of disability caused by illness. It afflicts an estimated 17% of individuals during their lifetimes at tremendous costs. A number of depressive patients are treated with antidepressant medication. The efficacy of antidepressant medication has been studied in a number of systematic reviews, and in recent years some of these reviews have shown that the efficacy is questionable for many patients. So are there other effective treatments for this serious illness?
Cognitive- and psychodynamic therapies are probably both significantly more effective for depression than no treatment, but only limited comparisons have been made between the two interventions. A Cochrane review shows that cognitive therapy has a preventive effect against recurrent depression, and that this effect may surpass the preventive effect of antidepressant medication. Mindfulness training may be an effective technique in preventing relapse in patients who have had at least 3 previous depressive episodes. But efficacy in treating currently depressed patients has not been studied.
Objective To perform a randomised clinical trial with blinded assessment of efficacy variables in order to study the effects of mindfulness based behavioral therapy (cognitive therapy and mindfulness) versus psychodynamic therapy in depressive patients.
Methods
A randomised clinical trial of 84 consecutive patients diagnosed with major depressive disorder, referred to the day clinic, Roskilde psychiatric services. The patients will be randomised to one of two interventions:
- MIBT (mindfulness-based behavioural therapy)
- PT (psychodynamic therapy)
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Janus Christian Jakobsen, Medical doctor
- Phone Number: +45 26186242
- Email: janusjakobsen@mac.com
Study Contact Backup
- Name: Erik Simonsen, Associate professor
- Phone Number: 47 327733
- Email: es@regionsjaelland.dk
Study Locations
-
-
Zeeland
-
Roskilde, Zeeland, Denmark, 4000
- Recruiting
- The day clinic for treatment of non-psychotic disorders (Roskilde Psychiatry)
-
Contact:
- Erik Simonsen, Associate professor
- Phone Number: +4547327733
- Email: es@regionsjaelland.dk
-
Contact:
- Kirsten Larsen, Medical doctor
- Phone Number: 47327733
- Email: kala@regionsjaelland.dk
-
Principal Investigator:
- Janus Christian Jakobsen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Aged 18 to 65 years
- Major depressive disorder (SCID I).
- BDI II > 13.
- Written informed consent.
Exclusion Criteria:
- Current psychosis, diagnosis of schizophrenia or schizotypal personality disorder (DSM IV-TR).
- Alcohol or substance abuse judged to require treatment in preference to depression (assessed during patient conference).
- Commenced or changed psychopharmacological treatment less than six weeks before randomisation.
- Pregnancy.
- No written informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mindfulness-based Behavioural Therapy (MIBT)
|
The MIBT treatment consists of weekly individual MIBT therapy (45-50 min.), together with weekly mindfulness-skills training group (1.5 hours). The treatment is based on the cognitive model of depression, but will, based on concrete problems, draw from alternative cognitive techniques in order to treat personality-related problems and will use elements from mindfulness. |
Active Comparator: PT (psychodynamic therapy)
|
The PT treatment consists of weekly individual PT therapy (45-50 min.), together with weekly PT group therapy (1.5 hours). The main elements of PT are the free-flowing, non-therapist guided dialogue, based on classic psychoanalytical free association. Basically, the role of the therapist is to set ground rules and organise the time, place and duration, to maintain a proper tone, and ultimately to ensure that a therapeutic process takes place using relevant interventions. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
17 item Hamilton rating scale for depression (score at the end of 18 weeks of day- treatment)
Time Frame: 0 weeks, 18 weeks, and 1 year
|
0 weeks, 18 weeks, and 1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
SCL-90-R (GSI score at the end of 18 weeks of day- treatment)
Time Frame: 0 weeks, 9 weeks, 18 weeks, and 1 year
|
0 weeks, 9 weeks, 18 weeks, and 1 year
|
The proportion of patients who achieve remission (Hamilton score < 8).
Time Frame: 0 weeks, 18 weeks, and 1 year
|
0 weeks, 18 weeks, and 1 year
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Jakobsen JC, Gluud C, Kongerslev M, Larsen KA, Sorensen P, Winkel P, Lange T, Sogaard U, Simonsen E. Third-wave cognitive therapy versus mentalisation-based treatment for major depressive disorder: a randomised clinical trial. BMJ Open. 2014 Aug 19;4(8):e004903. doi: 10.1136/bmjopen-2014-004903.
- Jakobsen JC, Gluud C, Kongerslev M, Larsen KA, Sorensen P, Winkel P, Lange T, Sogaard U, Simonsen E. 'Third wave' cognitive therapy versus mentalization-based therapy for major depressive disorder. A protocol for a randomised clinical trial. BMC Psychiatry. 2012 Dec 19;12:232. doi: 10.1186/1471-244X-12-232.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Mipsy trial
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Major Depressive Disorder
-
Shalvata Mental Health CenterUnknownMAjor Depressive DisorderIsrael
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDDIndia
-
Gangnam Severance HospitalCompletedMajor Depressive Disorder(MDD)Korea, Republic of
-
University College, LondonCompletedUnipolar Major Depressive DisorderUnited Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...Fondo de Investigacion SanitariaUnknown
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDD)India
-
Repurposed Therapeutics, Inc.Unknown
-
GlaxoSmithKlineCompletedMajor Depressive Disorder (MDD)United States
-
AccexibleRecruitingMajor Depressive Disorder (MDD)Spain
Clinical Trials on Mindfulness-based Behavioural Therapy (MIBT)
-
Huichao ZhangRecruitingDepression, Anxiety | End-of-lifeChina
-
University of British ColumbiaCompleted
-
University of British ColumbiaActive, not recruitingFemale Sexual DysfunctionCanada
-
University of BarcelonaCompletedDepression | Stress | Anxiety | Self Efficacy | Breast Cancer Female | HopefulnessTurkey
-
Chinese University of Hong KongNot yet recruitingMental Health Wellness 1 | Mental Well-being | Mental Health Issue | Precision Mental HealthHong Kong
-
Centre for Addiction and Mental HealthCompleted
-
University of ManitobaCompletedDepression | PTSD | Anxiety Disorders | Stress Disorders, PosttraumaticCanada
-
University of ManitobaCompletedDepressive Symptoms | Anxiety SymptomsCanada
-
London Metropolitan UniversityCompletedErectile DysfunctionUnited Kingdom
-
Mater Misericordiae University HospitalCompletedQuality of Life | Breast Cancer | Chronic Pain | Chronic Postsurgical PainIreland